Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation-Reference-Cited by-同舟云学术

Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation

Published:2012-10-22 Issue:1 Volume:344 Page:196-206
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Busby Robert W.,Kessler Marco M.,Bartolini Wilmin P.,Bryant Alexander P.,Hannig Gerhard,Higgins Carolyn S.,Solinga Robert M.,Tobin Jenny V.,Wakefield James D.,Kurtz Caroline B.,Currie Mark G.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference39 articles.

1. Effect of 5 Days Linaclotide on Transit and Bowel Function in Females With Constipation-Predominant Irritable Bowel Syndrome

2. Molecular Mechanisms of Thioredoxin and Glutaredoxin as Hydrogen Donors for Mammalian S Phase Ribonucleotide Reductase

3. The carboxypeptidase activity of pancreatin U.S.P;Bauer;J Am Pharm Assoc Am Pharm Assoc,1947

4. Production of neutralizing monoclonal antibodies to Escherichia coli heat-stable enterotoxin;Brandwein;Infect Immun,1985

5. Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of linaclotide in bowel preparation for colonoscopy in patients with constipation: A prospective randomized controlled study;Journal of Gastroenterology and Hepatology;2024-09-09

2. Triscysteine disulfide-directing motifs enabling design and discovery of multicyclic peptide binders;Nature Communications;2024-09-06

3. Safety and efficacy of linaclotide in children aged 2–5 years with functional constipation: Phase 2, randomized study;Journal of Pediatric Gastroenterology and Nutrition;2024-07-04

4. Examining linaclotide for the treatment of chronic idiopathic constipation;Expert Opinion on Pharmacotherapy;2024-07-02

5. Clinical effects of chemical drugs, fecal microbiota transplantation, probiotics, dietary fiber, and acupuncture in the treatment of chronic functional constipation: a systematic review and network meta-analysis;European Journal of Gastroenterology & Hepatology;2024-05-02